Page last updated: 2024-08-16

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and sr 144528

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with sr 144528 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deligia, F; Fernández-Ruiz, J; García-Arencibia, M; Gómez-Cañas, M; Goya, P; Hurst, DP; Jagerovic, N; Morales, P; Murineddu, G; Pazos, R; Pinna, GA; Ragusa, G; Reggio, PH1
Cooper, AG; Glass, M; Hook, S; MacDonald, C; Tyndall, JDA; Vernall, AJ1

Other Studies

2 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and sr 144528

ArticleYear
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonists.
    European journal of medicinal chemistry, 2015, Aug-28, Volume: 101

    Topics: Camphanes; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2015
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.
    European journal of medicinal chemistry, 2018, Feb-10, Volume: 145

    Topics: Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Indoles; Ligands; Models, Molecular; Molecular Structure; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2018